Skip to main content

Abstract

N-of-1 trials and review articles have recently been published in the areas of chronic pain, pediatrics, palliative care, complementary and alternative medicine, rare diseases, patient-centered care, the behavioral sciences and genomics. These are briefly reviewed and the current place of N-of-1 trials discussed. The chapter concludes with a vision for the future of N-of-1 trials.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Berde CB, Walco GA, Krane EJ, Anand KJ, Aranda JV, Craig KD, Dampier CD, Finkel JC, Grabois M, Johnston C, Lantos J, Lebel A, Maxwell LG, McGrath P, Oberlander TF, Schanberg LE, Stevens B, Taddio A, Von Baeyer CL, Yaster M, Zempsky WT (2012) Pediatric analgesic clinical trial designs, measures, and extrapolation: report of an FDA scientific workshop. Pediatrics 129(2):354–364. doi:10.1542/peds.2010-3591, Epub 2012 Jan 16

    Article  PubMed  Google Scholar 

  • Bush A. Montelukast in paediatric asthma: where we are now and what still needs to be done? 7 2014 Dec 11. pii: S1526-0542(14)00131-6. doi: 10.1016/j.prrv.2014.10.007

  • Camfield P, Gordon K, Dooley J, Camfield C (1996) Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: six "N of 1" trials. J Child Neurol 11(4):341–343

    Article  CAS  PubMed  Google Scholar 

  • Cook AM, Finlay IG, Butler-Keating RJ (2002) Recruiting into palliative care trials: lessons learnt from a feasibility study. Palliat Med 16:163–165

    Article  CAS  PubMed  Google Scholar 

  • Coxeter P, Schluter P, Eastwood H, Nikles J, Glasziou P (2003) Valerian does not reduce symptoms for patients with chronic insomnia in general practice. Complement Ther Med 11(4):215–222

    Article  CAS  PubMed  Google Scholar 

  • Currow DC, Plummer JL, Kutner JS, Samsa GP, Abernethy AP (2012) Analyzing phase III studies in hospice/palliative care. A solution that sits between intention-to-treat and per protocol analyses: the palliative-modified ITT analysis. J Pain Symptom Manag 44(4):595–603

    Article  Google Scholar 

  • Davidson KW, Peacock J, Kronish IM, Edmondson D (2014) Personalizing behavioral interventions through single-patient (N-of-1) trials. Soc Personal Psychol Compass 8(8):408–421

    Article  PubMed Central  PubMed  Google Scholar 

  • Davis MP, Mitchell GK (2012) Topics in research: structuring studies in palliative care. Curr Opin Support Palliat Care 6(4):483–489. doi:10.1097/SPC.0b013e32835843d7

    Article  PubMed  Google Scholar 

  • Duan N, Kravitz RL, Schmid CH (2013) Single-patient (N-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research. J Clin Epidemiol 66(8 Suppl):S21–S28. doi:10.1016/j.jclinepi.2013.04.006

    Article  PubMed Central  PubMed  Google Scholar 

  • Duggan CM, Mitchell G, Nikles CJ, Glasziou PP, Del Mar CB, Clavarino A (2000) Managing ADHD in general practice. N of 1 trials can help! Aust Fam Physician 29(12):1205–1209

    CAS  PubMed  Google Scholar 

  • Evans JJ, Gast DL, Perdices M, Manolov R (2014) Single case experimental designs: introduction to a special issue of neuropsychological rehabilitation. Neuropsychol Rehabil 24(3–4):305–314. doi:10.1080/09602011.2014.903198, Epub 2014 Apr 25

    Article  PubMed  Google Scholar 

  • Faber A, Keizer RJ, van den Berg PB, de Jong-van den Berg LT, Tobi H (2007) Use of double-blind placebo-controlled N-of-1 trials among stimulant-treated youths in the Netherlands: a descriptive study. Eur J Clin Pharmacol 63(1):57–63, Epub 2006 Nov 18

    Article  PubMed  Google Scholar 

  • Facey K, Granados A, Guyatt G, Kent A, Shah N, van der Wilt GJ, Wong-Rieger D (2014) Generating health technology assessment evidence for rare diseases. Int J Technol Assess Health Care 19:1–7

    Google Scholar 

  • Gewandter JS, Dworkin RH, Turk DC, McDermott MP, Baron R, Gastonguay MR, Gilron I, Katz NP, Mehta C, Raja SN, Senn S, Taylor C, Cowan P, Desjardins P, Dimitrova R, Dionne R, Farrar JT, Hewitt DJ, Iyengar S, Jay GW, Kalso E, Kerns RD, Leff R, Leong M, Petersen KL, Ravina BM, Rauschkolb C, Rice AS, Rowbotham MC, Sampaio C, Sindrup SH, Stauffer JW, Steigerwald I, Stewart J, Tobias J, Treede RD, Wallace M, White RE (2014) Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations. Pain 155(9):1683–1695. doi:10.1016/j.pain.2014.05.025, Epub 2014 May 24

    Article  PubMed Central  PubMed  Google Scholar 

  • Greenhill LL, Jensen PS, Abikoff H, Blumer JL, Deveaugh-Geiss J, Fisher C, Hoagwood K, Kratochvil CJ, Lahey BB, Laughren T, Leckman J, Petti TA, Pope K, Shaffer D, Vitiello B, Zeanah C (2003) Developing strategies for psychopharmacological studies in preschool children. J Am Acad Child Adolesc Psychiatry 42(4):406–414, Review

    Article  PubMed  Google Scholar 

  • Gupta S, Faughnan ME, Tomlinson GA, Bayoumi AM (2011) A framework for applying unfamiliar trial designs in studies of rare diseases. J Clin Epidemiol 64(10):1085–1094. doi:10.1016/j.jclinepi.2010.12.019, Epub 2011 May 6

    Article  PubMed  Google Scholar 

  • Hermet R, Burucia B, Sentilles-Monkam A (2002) The need for evidence-based proof in palliative care. Eur J Pall Care 9:104–107

    Google Scholar 

  • Huang H, Yang P, Xue J, Tang J, Ding L, Ma Y, Wang J, Guyatt GH, Vanniyasingam T, Zhang Y (2014) Evaluating the individualized treatment of traditional Chinese medicine: a pilot study of N-of-1 trials. Evid Based Complement Alternat Med 2014:148730. doi:10.1155/2014/148730, Epub 2014 Nov 11

    PubMed Central  PubMed  Google Scholar 

  • Huber AM, Tomlinson GA, Koren G, Feldman BM (2007) Amitriptyline to relieve pain in juvenile idiopathic arthritis: a pilot study using Bayesian metaanalysis of multiple N-of-1 clinical trials. J Rheumatol 34(5):1125–1132, Epub 2007 Apr 15

    CAS  PubMed  Google Scholar 

  • Kaput J, Morine M (2012) Discovery-based nutritional systems biology: developing N-of-1 nutrigenomic research. Int J Vitam Nutr Res 82(5):333–341. doi:10.1024/0300-9831/a000128

    Article  CAS  PubMed  Google Scholar 

  • Kent MA, Camfield CS, Camfield PR (1999) Double-blind methylphenidate trials: practical, useful, and highly endorsed by families. Arch Pediatr Adolesc Med 153(12):1292–1296

    Article  CAS  PubMed  Google Scholar 

  • Lee S, Lim N, Choi SM, Kim S (2012) Validation study of Kim’s sham needle by measuring facial temperature: an N-of-1 randomized double-blind placebo-controlled clinical trial. Evid Based Complement Alternat Med 2012:507937. doi:10.1155/2012/507937, Epub 2012 Mar 6

    PubMed Central  PubMed  Google Scholar 

  • Li J, Tian J, Ma B, Yang K (2013) N-of-1 trials in china. Complement Ther Med 21(3):190–194. doi:10.1016/j.ctim.2013.01.003, Epub 2013 Feb 18

    Article  PubMed  Google Scholar 

  • Lillie EO, Patay B, Diamant J, Issell B, Topol EJ, Schork NJ (2011) The N-of-1 clinical trial: the ultimate strategy for individualizing medicine? Per Med 8(2):161–173

    Article  PubMed Central  PubMed  Google Scholar 

  • Nathan PC, Tomlinson G, Dupuis LL, Greenberg ML, Ota S, Bartels U, Feldman BM (2006) A pilot study of ondansetron plus metopimazine vs. Ondansetron Monotherapy in children receiving highly emetogenic chemotherapy: a Bayesian randomized serial N-of-1 trials design. Support Care Cancer 14(3):268–276, Epub 2005 Jul 29

    Article  CAS  PubMed  Google Scholar 

  • Nikles CJ, Clavarino AM, Del Mar CB (2005) Using N-of-1 trials as a clinical tool to improve prescribing. Br J Gen Pract 55(512):175–180

    PubMed Central  PubMed  Google Scholar 

  • Nikles CJ, Mitchell GK, Del Mar CB, Clavarino AM, McNairn N (2006) An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder. Pediatrics 117(6):2040–2046

    Article  PubMed  Google Scholar 

  • Nikles CJ, McKinlay L, Mitchell GK, Carmont SA, Senior HE, Waugh MC, Epps A, Schluter PJ, Lloyd OT (2014) Aggregated n-of-1 trials of central nervous system stimulants versus placebo for paediatric traumatic brain injury–a pilot study. Trials 15:54. doi:10.1186/1745-6215-15-54

    Article  PubMed Central  PubMed  Google Scholar 

  • Sung L, Feldman BM (2006) N-of-1 trials: innovative methods to evaluate complementary and alternative medicines in pediatric cancer. J Pediatr Hematol Oncol 28(4):263–266

    Article  PubMed  Google Scholar 

  • Sung L, Tomlinson GA, Greenberg ML, Koren G, Judd P, Ota S, Feldman BM (2007) Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients. Eur J Cancer 43(8):1269–1275, Epub 2007 Mar 23

    Article  CAS  PubMed  Google Scholar 

  • Suri R (2005) The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis. BioDrugs 19(3):135–144

    Article  CAS  PubMed  Google Scholar 

  • Suri R, Metcalfe C, Wallis C, Bush A (2004) Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis. Pediatr Pulmonol 37(4):305–310

    Article  PubMed  Google Scholar 

  • Taragin D, Berman S, Zelnik N, Karni A, Tirosh E (2013) Parents’ attitudes toward methylphenidate using n-of-1 trial: a pilot study. Atten Defic Hyperact Disord 5(2):105–109. doi:10.1007/s12402-012-0099-x. Epub 2012 Dec 16

    Article  PubMed  Google Scholar 

  • Tate RL, McDonald S, Perdices M, Togher L, Schultz R, Savage S (2008) Rating the methodological quality of single-subject designs and n-of-1 trials: introducing the single-case experimental design (SCED) scale. Neuropsychol Rehabil 18(4):385–401. doi:10.1080/09602010802009201

    Article  PubMed  Google Scholar 

  • Tate RL, Perdices M, Rosenkoetter U, Wakim D, Godbee K, Togher L, McDonald S (2013) Revision of a method quality rating scale for single-case experimental designs and n-of-1 trials: the 15-item risk of bias in N-of-1 trials (RoBiNT) scale. Neuropsychol Rehabil 23(5):619–638. doi:10.1080/09602011.2013.824383, Epub 2013 Sep 9

    Article  PubMed  Google Scholar 

  • Tate RL, Perdices M, McDonald S, Togher L, Rosenkoetter U (2014) The design, conduct and report of single-case research: resources to improve the quality of the neurorehabilitation literature. Neuropsychol Rehabil 24(3–4):315–331. doi:10.1080/09602011.2013.875043, Epub 2014 Apr 7

    Article  PubMed  Google Scholar 

  • Yuhong H, Qian L, Yu L, Yingqiang Z, Yanfen L, Shujing Y, Shufang Q, Lanjun S, Shuxuan Z, Baohe W (2013) An n-of-1 trial service in clinical practice: testing the effectiveness of Liuwei Dihuang decoction for kidney-Yin defisciency syndrome. Evid Based Complement Alternat Med 2013:827915. doi:10.1155/2013/827915, Epub 2013 Sep 23

    Article  PubMed Central  PubMed  Google Scholar 

  • Zucker DR, Schmid CH, McIntosh MW, D’Agostino RB, Selker HP, Lau J (1997) Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. J Clin Epidemiol 50(4):401–410

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jane Nikles .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Nikles, J. (2015). Where Are N-of-1 Trials Headed?. In: Nikles, J., Mitchell, G. (eds) The Essential Guide to N-of-1 Trials in Health. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7200-6_17

Download citation

Publish with us

Policies and ethics